Primary Site >> Biliary tract Cancer

Gene >> FGFR1

Journal: J Clin Pathol. 2016 May;69(5):403-8.
Title: Comprehensive genomic profiling of extrahepatic cholangiocarcinoma reveals a long tail of therapeutic targets.
Author: Lee, Hwajeong|Wang, Kai|Johnson, Adrienne|Jones, David M|Ali, Siraj M|Elvin, Julia A|Yelensky, Roman|Lipson, Doron|Miller, Vincent A|Stephens, Philip J|Javle, Milind|Ross, Jeffrey S
PMID: 26500333
Journal: PLoS One. 2016 Sep 14;11(9):e0162594.
Title: Preclinical Activity of ARQ 087, a Novel Inhibitor Targeting FGFR Dysregulation.
Author: Hall, Terence G|Yu, Yi|Eathiraj, Sudharshan|Wang, Yunxia|Savage, Ronald E|Lapierre, Jean-Marc|Schwartz, Brian|Abbadessa, Giovanni
PMID: 27627808
Journal: Br J Cancer. 2017 Nov 21;117(11):1592-1599.
Title: A Phase 1 study of ARQ 087, an oral pan-FGFR inhibitor in patients with advanced solid tumours.
Author: Papadopoulos, K P|El-Rayes, B F|Tolcher, A W|Patnaik, A|Rasco, D W|Harvey, R D|LoRusso, P M|Sachdev, J C|Abbadessa, G|Savage, R E|Hall, T|Schwartz, B|Wang, Y|Kazakin, J|Shaib, W L
PMID: 28972963